2019
Immunodeficiency at Antiretroviral Therapy Start: Five-Year Adult Data (2012–2017) Based on Evolving National Policies in Rural Mozambique
Arinze F, Gong W, Green A, De Schacht C, Carlucci J, Silva W, Claquin G, Tique J, Stefanutto M, Graves E, Van Rompaey S, Alvim M, Tomo S, Moon T, Wester C. Immunodeficiency at Antiretroviral Therapy Start: Five-Year Adult Data (2012–2017) Based on Evolving National Policies in Rural Mozambique. AIDS Research And Human Retroviruses 2019, 36: 39-47. PMID: 31359762, PMCID: PMC9836686, DOI: 10.1089/aid.2019.0043.Peer-Reviewed Original ResearchConceptsCD4 cell countMedian CD4 cell countAntiretroviral therapyART initiationSevere immunodeficiencyCell countMedian changeHealth facilitiesHigher median CD4 cell countsMultivariable logistic regression modelAdvanced HIV diseaseAntiretroviral therapy (ART) startMedian CD4 cellProvider-initiated testingCombination antiretroviral therapyStage 4 diseaseTreatment-naive adultsLogistic regression modelsUniversal HIVOlder patientsCD4 cellsHIV diseaseTherapy startMale sexFemale sex
2014
Clinical Mentorship of Nurse Initiated Antiretroviral Therapy in Khayelitsha, South Africa: A Quality of Care Assessment
Green A, de Azevedo V, Patten G, Davies M, Ibeto M, Cox V. Clinical Mentorship of Nurse Initiated Antiretroviral Therapy in Khayelitsha, South Africa: A Quality of Care Assessment. PLOS ONE 2014, 9: e98389. PMID: 24887260, PMCID: PMC4041881, DOI: 10.1371/journal.pone.0098389.Peer-Reviewed Original ResearchConceptsAntiretroviral treatmentEligible patientsLong-term side effectsART start dateART-eligible patientsBaseline blood workClinical mentorship programInitiated antiretroviral therapyUniversal ART accessHIV-positive patientsTB/HIVNumber of patientsCross-sectional studyRoutine clinical dataResource limited settingsHIV treatment accessART initiationNurse initiationAntiretroviral therapyPatient characteristicsPositive patientsMore patientsBlood workClinical presentationNurses' confidence